Schneeberger Daniel
CIK 1861120
Transactions on file
49
Open-market buys
43
Win rate (buys)
91%
43 scored
Avg % since filing (buys)
+26.0%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-08 | 2026-09-03 | TENX TENAX THERAPEUTICS, INC. | 10% | Buy | 900,000 | $1.60M | +4.4% | open → |
| 2026-09-02 | 2026-09-02 | TENX TENAX THERAPEUTICS, INC. | 10% | Buy | 187,704 | $337.6K | +3.4% | open → |
| 2026-09-02 | 2026-09-01 | TENX TENAX THERAPEUTICS, INC. | 10% | Buy | 179,058 | $321.6K | +3.6% | open → |
| 2026-09-02 | 2026-08-31 | TENX TENAX THERAPEUTICS, INC. | 10% | Buy | 403,571 | $722.6K | +3.9% | open → |
| 2026-08-25 | 2026-08-24 | TENX TENAX THERAPEUTICS, INC. | 10% | Buy | 107,374 | $188.4K | +6.0% | open → |
| 2026-08-25 | 2026-08-21 | TENX TENAX THERAPEUTICS, INC. | 10% | Buy | 716,369 | $1.27M | +5.2% | open → |
| 2026-08-25 | 2026-08-20 | TENX TENAX THERAPEUTICS, INC. | 10% | Buy | 202,124 | $359.5K | +4.6% | open → |
| 2026-08-03 | 2026-07-31 | NXTC NextCure, Inc. | 10% | Buy | 8,003 | $38.4K | +68.1% | open → |
| 2026-08-03 | 2026-07-31 | NXTC NextCure, Inc. | 10% | Buy | 25,000 | $124.5K | +62.0% | open → |
| 2026-08-03 | 2026-07-31 | NXTC NextCure, Inc. | 10% | Buy | 3,300 | $16.4K | +62.2% | open → |
| 2026-08-03 | 2026-07-30 | NXTC NextCure, Inc. | 10% | Buy | 77,850 | $385.8K | +62.8% | open → |
| 2026-08-03 | 2026-07-30 | NXTC NextCure, Inc. | 10% | Buy | 100,000 | $490.0K | +64.7% | open → |
| 2026-08-03 | 2026-07-30 | NXTC NextCure, Inc. | 10% | Buy | 25,000 | $120.3K | +67.7% | open → |
| 2026-08-03 | 2026-07-30 | NXTC NextCure, Inc. | 10% | Buy | 20,000 | $100.0K | +61.4% | open → |
| 2026-08-03 | 2026-07-30 | NXTC NextCure, Inc. | 10% | Buy | 20,000 | $100.0K | +61.4% | open → |
| 2026-08-03 | 2026-07-30 | NXTC NextCure, Inc. | 10% | Buy | 50,000 | $248.6K | +62.3% | open → |
| 2026-07-29 | 2026-07-29 | NXTC NextCure, Inc. | 10% | Buy | 1,600 | $8.0K | +61.4% | open → |
| 2026-07-29 | 2026-07-29 | NXTC NextCure, Inc. | 10% | Buy | 1,810 | $9.1K | +61.4% | open → |
| 2026-07-29 | 2026-07-28 | NXTC NextCure, Inc. | 10% | Buy | 6,400 | $31.7K | +63.0% | open → |
| 2026-07-29 | 2026-07-27 | NXTC NextCure, Inc. | 10% | Buy | 7,798 | $39.0K | +61.4% | open → |
| 2026-07-17 | 2026-07-15 | INM InMed Pharmaceuticals Inc. | 10% | Buy | 1,000 | $1.6K | -5.5% | open → |
| 2026-05-21 | 2026-05-19 | INM InMed Pharmaceuticals Inc. | 10% | Buy | 200,000 | $299.8K | -1.9% | open → |
| 2026-05-21 | 2026-05-19 | INM InMed Pharmaceuticals Inc. | 10% | Buy | 200,000 | $312.1K | -5.8% | open → |
| 2026-05-21 | 2026-05-19 | INM InMed Pharmaceuticals Inc. | 10% | Buy | 68,551 | $109.7K | -8.1% | open → |
| 2026-05-21 | 2026-05-19 | RLYB Rallybio Corp | 10% | Buy | 200 | $2.8K | +17.1% | open → |
| 2026-05-21 | 2026-05-19 | RLYB Rallybio Corp | 10% | Buy | 10,000 | $139.8K | +15.6% | open → |
| 2026-05-21 | 2026-05-18 | RLYB Rallybio Corp | 10% | Buy | 6,009 | $84.0K | +15.6% | open → |
| 2026-05-16 | 2026-05-15 | RLYB Rallybio Corp | 10% | Buy | 200 | $2.8K | +15.8% | open → |
| 2026-05-16 | 2026-05-15 | RLYB Rallybio Corp | 10% | Buy | 100 | $1.4K | +17.1% | open → |
| 2026-05-16 | 2026-05-13 | RLYB Rallybio Corp | 10% | Buy | 75,178 | $1.05M | +15.4% | open → |
| 2026-05-16 | 2026-05-13 | RLYB Rallybio Corp | 10% | Buy | 4,081 | $56.3K | +17.1% | open → |
| 2026-05-14 | 2026-05-12 | RLYB Rallybio Corp | 10% | Buy | 800 | $11.1K | +16.9% | open → |
| 2026-05-14 | 2026-05-11 | RLYB Rallybio Corp | 10% | Buy | 19,900 | $278.6K | +15.4% | open → |
| 2026-05-14 | 2026-05-11 | RLYB Rallybio Corp | 10% | Buy | 25,000 | $350.0K | +15.4% | open → |
| 2026-05-14 | 2026-05-11 | RLYB Rallybio Corp | 10% | Buy | 5,100 | $71.4K | +15.4% | open → |
| 2025-04-11 | 2025-04-09 | KROS Keros Therapeutics, Inc. | 10% | Buy | 74,333 | $767.9K | +7.3% | open → |
| 2025-04-11 | 2025-04-09 | KROS Keros Therapeutics, Inc. | 10% | Buy | 18,560 | $174.5K | +17.9% | open → |
| 2025-04-11 | 2025-04-09 | KROS Keros Therapeutics, Inc. | 10% | Buy | 16,365 | $153.8K | +17.9% | open → |
| 2025-04-11 | 2025-04-09 | KROS Keros Therapeutics, Inc. | 10% | Buy | 325,000 | $3.20M | +12.4% | open → |
| 2025-04-11 | 2025-04-09 | KROS Keros Therapeutics, Inc. | 10% | Buy | 500,000 | $5.17M | +7.3% | open → |
| 2025-06-24 | 2025-06-20 | KROS Keros Therapeutics, Inc. | 10% | X | 200 | $14.0K | -84.2% | open → |
| 2025-06-24 | 2025-06-20 | KROS Keros Therapeutics, Inc. | 10% | X | 100 | $6.0K | -81.5% | open → |
| 2025-06-24 | 2025-06-20 | KROS Keros Therapeutics, Inc. | 10% | X | 1,400 | $98.0K | -84.2% | open → |
| 2026-05-07 | 2026-05-05 | RLYB Rallybio Corp | 10% | Buy | 35,101 | $491.3K | +15.5% | open → |
| 2026-05-07 | 2026-05-04 | RLYB Rallybio Corp | 10% | Buy | 116,904 | $1.63M | +15.7% | open → |
| 2026-05-07 | 2026-05-04 | RLYB Rallybio Corp | 10% | Buy | 3,900 | $54.2K | +16.3% | open → |
| 2025-10-15 | 2025-10-15 | KROS Keros Therapeutics, Inc. | 10% | Sale | 743,358 | $13.19M | -37.6% | open → |
| 2025-10-15 | 2025-10-15 | KROS Keros Therapeutics, Inc. | 10% | Sale | 254,669 | $4.52M | -37.6% | open → |
| 2025-10-15 | 2025-10-15 | KROS Keros Therapeutics, Inc. | 10% | Sale | 4,391,237 | $77.94M | -37.6% | open → |
